Atopic Dermatitis 10/19

May 25, 20221 min read

VIDEO: Depressive symptoms linked to AD severity

Depressive symptoms are closely linked to AD severity and can fluctuate alongside AD severity.

May 18, 20221 min read

VIDEO: Dupilumab study shows safety and efficacy for up to four years in AD patients

Dupilumab shows safety and efficacy for up to four years in treatment of moderate-to-severe atopic dermatitis in adults.

Apr 28, 20221 min read

VIDEO: Dupilumab and adjuvant tacrolimus improves severity of AD, new study shows

Patients with AD are more likely to achieve mild disease severity when treated with dupilumab and adjuvant tacrolimus vs dupilumab alone.

Apr 21, 20221 min read

VIDEO: Inaugural Atopic Dermatitis Summit open for registration

Registration is open for the inaugural Atopic Dermatitis Summit. The virtual even will be held on Saturday, April 23, 2022 at 10am EDT.

Apr 18, 20221 min read

Eczema a shared risk factor for anxiety and depression

A retrospective review has revealed that eczema can be associated with a 63% increased chance of patients also developing either...

Mar 30, 20221 min read

VIDEO: Difamilast ointment shows efficacy in treating atopic dermatitis

A new study found difamilast ointment 1% to be safe and efficacious in the treatment of atopic dermatitis.

Mar 10, 20221 min read

VIDEO: Dupilumab-induced ocular surface disease more frequently associated with AD, study shows

Dupilumab-induced ocular surface disease appears to occur more frequently in patients with AD than with other skin conditions.

Jan 31, 20221 min read

AD symptoms get worse during premenstrual period

A research letter published in the Journal of the American Academy of Dermatology has outlined the degree to which symptoms of atopic...

10

Featured Posts